Overview
Fetal carbamazepine syndrome, also known as carbamazepine embryopathy, is a rare condition that occurs when a developing baby is exposed to the medication carbamazepine (brand names include Tegretol and Carbatrol) during pregnancy. Carbamazepine is an anticonvulsant drug commonly used to treat epilepsy, bipolar disorder, and certain types of nerve pain. When taken during pregnancy, especially during the first trimester, it can interfere with normal fetal development and cause a pattern of birth defects. The syndrome can affect multiple parts of the body. Common features include distinctive facial characteristics such as a short nose, a long upper lip, upward-slanting eyes, and widely spaced eyes. Children may also be born with fingernail underdevelopment (small or poorly formed nails), growth delays, and a smaller-than-expected head size (microcephaly). Some children experience developmental delays and mild to moderate intellectual disability. Neural tube defects, particularly spina bifida, are a well-known serious complication. Heart defects and cleft palate may also occur in some cases. There is no cure for fetal carbamazepine syndrome, and treatment focuses on managing individual symptoms. Early intervention programs, physical therapy, speech therapy, and special education services can help children reach their full potential. Surgical correction may be needed for heart defects, cleft palate, or neural tube defects. The severity of the condition varies widely — some children are mildly affected while others face more significant challenges. Prevention through careful medication management before and during pregnancy is the most important strategy.
Key symptoms:
Small head sizeShort nose with a flat bridgeLong upper lipUpward-slanting eyesWidely spaced eyesSmall or underdeveloped fingernailsGrowth delays before and after birthDevelopmental delaysMild to moderate intellectual disabilityNeural tube defects such as spina bifidaHeart defectsCleft palate or cleft lipLow birth weightPoor muscle tone in infancy
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsCARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: FDA approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
CARBAMAZEPINE: New indication approved
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Fetal carbamazepine syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Fetal carbamazepine syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Fetal carbamazepine syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Fetal carbamazepine syndrome.
Community
No community posts yet. Be the first to share your experience with Fetal carbamazepine syndrome.
Start the conversation →Latest news about Fetal carbamazepine syndrome
No recent news articles for Fetal carbamazepine syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe are my child's specific features, and what does this mean for their development?,What specialists should my child see, and how often?,Are there any heart defects or neural tube defects that need immediate treatment?,What early intervention therapies do you recommend, and when should they start?,What should I watch for as warning signs that something needs urgent attention?,If I plan to have more children, what steps can I take to reduce the risk of this happening again?,Are there any support groups or resources for families affected by this condition?
Common questions about Fetal carbamazepine syndrome
What is Fetal carbamazepine syndrome?
Fetal carbamazepine syndrome, also known as carbamazepine embryopathy, is a rare condition that occurs when a developing baby is exposed to the medication carbamazepine (brand names include Tegretol and Carbatrol) during pregnancy. Carbamazepine is an anticonvulsant drug commonly used to treat epilepsy, bipolar disorder, and certain types of nerve pain. When taken during pregnancy, especially during the first trimester, it can interfere with normal fetal development and cause a pattern of birth defects. The syndrome can affect multiple parts of the body. Common features include distinctive fa
How is Fetal carbamazepine syndrome inherited?
Fetal carbamazepine syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Fetal carbamazepine syndrome typically begin?
Typical onset of Fetal carbamazepine syndrome is neonatal. Age of onset can vary across affected individuals.